Offer - Urjas Oil for just ₹ 1 X
Mabtas 500 Infusion is a commercial drug that is prescribed in the form of Infusion. Primarily, it is used for the treatment of Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia. Mabtas 500 Infusion also has some secondary and off-label uses. These are listed below.
The right dosage of Mabtas 500 Infusion depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
The side effects typically associated with Mabtas 500 Infusion include Weakness. Some other side effects of Mabtas 500 Infusion have been listed ahead. These side effects of Mabtas 500 Infusion are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Mabtas 500 Infusion's effect during pregnancy is Moderate and Severe while nursing. It is important to know if Mabtas 500 Infusion has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Mabtas 500 Infusion related warnings section.
Mabtas 500 Infusion is contraindicated in people with pre-existing medical conditions like Hyperkalemia as it can result in adverse effects. Other contraindications of Mabtas 500 Infusion have been discussed in the sections ahead.
Drug reaction of Mabtas 500 Infusion with other medicines has been reported. A complete list of these interactions is given below.
In addition to the above precautions for Mabtas 500 Infusion, it is important to know that it is not safe while driving, and is not habit-forming.
Mabtas 500 Infusion is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Mabtas 500 Infusion safe for pregnant women?
Mabtas can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Mabtas right away. Take your doctor's advice before taking it again.
Is the use of Mabtas 500 Infusion safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Mabtas. So it is adviced to consult the doctor before using it.
What is the effect of Mabtas 500 Infusion on the Kidneys?
There can be some harmful effects on your kidneys after taking Mabtas. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Mabtas 500 Infusion on the Liver?
Mabtas does not damage the liver.
What is the effect of Mabtas 500 Infusion on the Heart?
There may be an adverse effect on the heart after taking Mabtas. If you observe any side effects on your body then stop taking this drug. Restart this medicine only if your doctor advises you to do so.
If you are suffering from any of the following diseases, you should not take Mabtas 500 Infusion unless your doctor advises you to do so -
Is this Mabtas 500 Infusion habit forming or addictive?
No, you will not get addicted to Mabtas 500 Infusion.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Mabtas 500 Infusion as you may feel sleepy.
Is it safe?
Yes, but take Mabtas 500 Infusion only as per medical advice.
Is it able to treat mental disorders?
No, the use of Mabtas 500 Infusion in mental disorders is not effective.
Interaction between Food and Mabtas 500 Infusion
You can take Mabtas 500 Infusion with food.
Interaction between Alcohol and Mabtas 500 Infusion
No research has been done on this till date. Therefore, it is not known what the effect of taking Mabtas 500 Infusion with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rituxan (rituximab)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1106-1109
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 872